NO20042449L - Injection solution comprising an LHRH antagonist - Google Patents

Injection solution comprising an LHRH antagonist

Info

Publication number: NO20042449L
Authority: NO; Norway
Prior art keywords: injection solution; lhrh antagonist; lhrh; antagonist; injection
Prior art date: 2001-11-26

Application number

NO20042449A

Other languages

Norwegian (no)

Other versions

NO333364B1 (en

Inventor

Juergen Engel

Horst Bauer

Werner Sarlikiotis

Matthias Rischer

Frank Guethlein

Dominique Di Stefano

Original Assignee

Zentaris Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-26

Filing date

2004-06-11

Publication date

2004-06-11

2004-06-11 Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh

2004-06-11 Publication of NO20042449L publication Critical patent/NO20042449L/en

2013-05-13 Publication of NO333364B1 publication Critical patent/NO333364B1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Reproductive Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oil, Petroleum & Natural Gas (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Manufacturing Of Micro-Capsules (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20042449A 2001-11-26 2004-06-11 Aqueous injection solution comprising an LHRH antagonist as well as a method of preparation NO333364B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10157628A DE10157628A1 (en)	2001-11-26	2001-11-26	Solution for injection of an LHRH antagonist
PCT/EP2002/012798 WO2003045419A1 (en)	2001-11-26	2002-11-15	Injection solution comprising an lhrh antagonist

Publications (2)

Publication Number	Publication Date
NO20042449L true NO20042449L (en)	2004-06-11
NO333364B1 NO333364B1 (en)	2013-05-13

Family

ID=7706799

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042449A NO333364B1 (en)	2001-11-26	2004-06-11	Aqueous injection solution comprising an LHRH antagonist as well as a method of preparation

Country Status (32)

Country	Link
EP (1)	EP1448221B1 (en)
JP (1)	JP4343693B2 (en)
KR (1)	KR100936636B1 (en)
CN (1)	CN100404068C (en)
AR (1)	AR037424A1 (en)
AT (1)	ATE350050T1 (en)
AU (1)	AU2002365504B2 (en)
BR (1)	BRPI0214412B8 (en)
CO (1)	CO5580793A2 (en)
CY (1)	CY1106401T1 (en)
DE (2)	DE10157628A1 (en)
DK (1)	DK1448221T3 (en)
EA (1)	EA010787B1 (en)
ES (1)	ES2276970T3 (en)
GE (1)	GEP20063861B (en)
HR (1)	HRP20040587B1 (en)
HU (1)	HU230992B1 (en)
IL (2)	IL161894A0 (en)
IS (1)	IS2725B (en)
ME (1)	ME00499B (en)
MX (1)	MXPA04005018A (en)
NO (1)	NO333364B1 (en)
NZ (1)	NZ533712A (en)
PL (1)	PL206199B1 (en)
PT (1)	PT1448221E (en)
RS (1)	RS51408B (en)
RU (1)	RU2322969C2 (en)
SI (1)	SI1448221T1 (en)
TW (1)	TWI312283B (en)
UA (1)	UA81612C2 (en)
WO (1)	WO2003045419A1 (en)
ZA (1)	ZA200404051B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7658938B2 (en)	1999-02-22	2010-02-09	Merrion Reasearch III Limited	Solid oral dosage form containing an enhancer
US8119159B2 (en)	1999-02-22	2012-02-21	Merrion Research Iii Limited	Solid oral dosage form containing an enhancer
MX2008012678A (en)	2006-04-07	2008-12-17	Merrion Res Iii Ltd	Solid oral dosage form containing an enhancer.
CA2723541A1 (en)	2008-05-07	2009-11-12	Merrion Research Iii Limited	Compositions of peptides and processes of preparation thereof
WO2011120033A1 (en)	2010-03-26	2011-09-29	Merrion Research Iii Limited	Pharmaceutical compositions of selective factor xa inhibitors for oral administration
CA2819234A1 (en)	2011-01-07	2012-07-12	Merrion Research Iii Limited	Pharmaceutical compositions of iron for oral administration
CN103690560B (en) *	2013-12-17	2016-08-17	辽宁海思科制药有限公司	A kind of Invert sugar electrolyte injection pharmaceutical composition and preparation method thereof
WO2016120378A1 (en)	2015-01-29	2016-08-04	Novo Nordisk A/S	Tablets comprising glp-1 agonist and enteric coating
RU2614234C2 (en) *	2015-03-31	2017-03-23	Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН)	PHARMACEUTICAL COMPOSITION BASED ON 3-(4-METHYLIMIDAZOLE-1-YL)IMIDAZO[1,2-b][1,2,4,5]TETRAZINE AS ANTI-TUMOR AGENT
KR20190112029A (en) *	2017-01-30	2019-10-02	안테브 리미티드	A composition comprising at least one GNRH antagonist
PT3811927T (en)	2019-10-24	2021-12-14	Sun Pharmaceutical Ind Ltd	A stable parenteral dosage form of cetrorelix acetate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4800191A (en) *	1987-07-17	1989-01-24	Schally Andrew Victor	LHRH antagonists
US5140009A (en) *	1988-02-10	1992-08-18	Tap Pharmaceuticals, Inc.	Octapeptide LHRH antagonists
US5300492A (en) *	1988-02-10	1994-04-05	Tap Pharmaceuticals	LHRH analogs
DE4305225A1 (en) *	1993-02-19	1994-08-25	Asta Medica Ag	New manufacturing process for Cetrorelix lyophilisate
HK1049117A1 (en) *	1999-09-23	2003-05-02	赞塔里斯有限公司	Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
DE10024451A1 (en) *	2000-05-18	2001-11-29	Asta Medica Ag	Pharmaceutical dosage form for peptides, process for their preparation and use

2001
- 2001-11-26 DE DE10157628A patent/DE10157628A1/en not_active Withdrawn
2002
- 2002-11-15 DK DK02790384T patent/DK1448221T3/en active
- 2002-11-15 KR KR1020047007807A patent/KR100936636B1/en not_active Expired - Lifetime
- 2002-11-15 RU RU2004119821/15A patent/RU2322969C2/en active
- 2002-11-15 HU HU0401986A patent/HU230992B1/en unknown
- 2002-11-15 AU AU2002365504A patent/AU2002365504B2/en not_active Expired
- 2002-11-15 ME MEP-2008-800A patent/ME00499B/en unknown
- 2002-11-15 WO PCT/EP2002/012798 patent/WO2003045419A1/en not_active Ceased
- 2002-11-15 MX MXPA04005018A patent/MXPA04005018A/en active IP Right Grant
- 2002-11-15 UA UA20040503816A patent/UA81612C2/en unknown
- 2002-11-15 EA EA200400742A patent/EA010787B1/en unknown
- 2002-11-15 JP JP2003546920A patent/JP4343693B2/en not_active Expired - Lifetime
- 2002-11-15 EP EP02790384A patent/EP1448221B1/en not_active Expired - Lifetime
- 2002-11-15 HR HR20040587A patent/HRP20040587B1/en not_active IP Right Cessation
- 2002-11-15 BR BRPI0214412A patent/BRPI0214412B8/en not_active IP Right Cessation
- 2002-11-15 IL IL16189402A patent/IL161894A0/en unknown
- 2002-11-15 AT AT02790384T patent/ATE350050T1/en active
- 2002-11-15 GE GE5568A patent/GEP20063861B/en unknown
- 2002-11-15 PT PT02790384T patent/PT1448221E/en unknown
- 2002-11-15 PL PL369548A patent/PL206199B1/en unknown
- 2002-11-15 SI SI200230505T patent/SI1448221T1/en unknown
- 2002-11-15 ES ES02790384T patent/ES2276970T3/en not_active Expired - Lifetime
- 2002-11-15 NZ NZ533712A patent/NZ533712A/en not_active IP Right Cessation
- 2002-11-15 CN CNB028234901A patent/CN100404068C/en not_active Expired - Lifetime
- 2002-11-15 DE DE50209193T patent/DE50209193D1/en not_active Expired - Lifetime
- 2002-11-15 RS YUP-449/04A patent/RS51408B/en unknown
- 2002-11-20 TW TW091133846A patent/TWI312283B/en not_active IP Right Cessation
- 2002-11-25 AR ARP020104523A patent/AR037424A1/en not_active Application Discontinuation
2004
- 2004-05-06 IS IS7251A patent/IS2725B/en unknown
- 2004-05-10 IL IL161894A patent/IL161894A/en active IP Right Grant
- 2004-05-14 CO CO04044748A patent/CO5580793A2/en not_active Application Discontinuation
- 2004-05-25 ZA ZA2004/04051A patent/ZA200404051B/en unknown
- 2004-06-11 NO NO20042449A patent/NO333364B1/en not_active IP Right Cessation
2007
- 2007-03-20 CY CY20071100391T patent/CY1106401T1/en unknown

Also Published As

Publication number	Publication date
AR037424A1 (en)	2004-11-10
CO5580793A2 (en)	2005-11-30
EA010787B1 (en)	2008-10-30
TWI312283B (en)	2009-07-21
JP4343693B2 (en)	2009-10-14
GEP20063861B (en)	2006-06-26
PT1448221E (en)	2007-03-30
DK1448221T3 (en)	2007-03-19
DE10157628A1 (en)	2003-06-12
WO2003045419A1 (en)	2003-06-05
TW200300352A (en)	2003-06-01
HK1073078A1 (en)	2005-09-23
IS7251A (en)	2004-05-06
EA200400742A1 (en)	2004-12-30
UA81612C2 (en)	2008-01-25
RS51408B (en)	2011-02-28
IS2725B (en)	2011-03-15
ME00499B (en)	2011-10-10
IL161894A0 (en)	2005-11-20
EP1448221B1 (en)	2007-01-03
NO333364B1 (en)	2013-05-13
CN1592630A (en)	2005-03-09
KR20040058312A (en)	2004-07-03
PL206199B1 (en)	2010-07-30
HUP0401986A3 (en)	2012-09-28
RU2004119821A (en)	2005-04-20
MXPA04005018A (en)	2004-08-11
RU2322969C2 (en)	2008-04-27
CY1106401T1 (en)	2011-10-12
RS44904A (en)	2006-10-27
HRP20040587A2 (en)	2004-10-31
NZ533712A (en)	2006-01-27
BRPI0214412B8 (en)	2021-05-25
BR0214412A (en)	2004-09-14
BRPI0214412B1 (en)	2016-01-05
HU230992B1 (en)	2019-08-28
IL161894A (en)	2014-05-28
AU2002365504A1 (en)	2003-06-10
SI1448221T1 (en)	2007-06-30
AU2002365504B2 (en)	2007-06-28
HRP20040587B1 (en)	2008-01-31
ES2276970T3 (en)	2007-07-01
PL369548A1 (en)	2005-05-02
CN100404068C (en)	2008-07-23
KR100936636B1 (en)	2010-01-14
EP1448221A1 (en)	2004-08-25
ATE350050T1 (en)	2007-01-15
DE50209193D1 (en)	2007-02-15
JP2005510544A (en)	2005-04-21
HUP0401986A2 (en)	2005-01-28
ZA200404051B (en)	2005-05-25

Publication	Publication Date	Title
DE60222245D1 (en)	2007-10-18	INJECTION DEVICE
DE60112678D1 (en)	2005-09-22	DIRECT INJECTION OTTOMOTOR
DE50213435D1 (en)	2009-05-20	FUEL INJECTION VALVE-SPARK-COMBINATION
DE50212586D1 (en)	2008-09-11	FUEL INJECTION VALVE-SPARK-COMBINATION
DE60232771D1 (en)	2009-08-13	Fuel injection system
DE50211785D1 (en)	2008-04-10	FUEL INJECTION
DE50214553D1 (en)	2010-09-09	FUEL INJECTION
EP1264611A4 (en)	2004-12-08	SYRINGE
DE50209245D1 (en)	2007-02-22	NEUROPROTEKTIVES MEDICAMENT
DE50212423D1 (en)	2008-08-14	Fuel injection system
DE50203953D1 (en)	2005-09-22	FUEL INJECTION DEVICE
DK1372771T3 (en)	2007-05-21	injection System
DE50208012D1 (en)	2006-10-12	FUEL INJECTION DEVICE
NO20042449L (en)	2004-06-11	Injection solution comprising an LHRH antagonist
DE50206023D1 (en)	2006-05-04	FUEL INJECTION
DE50107401D1 (en)	2005-10-20	INJECTOR
DE10196460T1 (en)	2003-10-02	Selbstzerstör syringe
DE50103958D1 (en)	2004-11-11	INJECTION
DE50210240D1 (en)	2007-07-12	FUEL INJECTION
DE60223796D1 (en)	2008-01-10	NEEDLE ARRANGEMENT
FR2811378B1 (en)	2007-06-22	INJECTOR
DE10111783B4 (en)	2005-10-20	injection
DE50209869D1 (en)	2007-05-16	FUEL INJECTION DEVICE
DE50112538D1 (en)	2007-07-12	injection
DE50211807D1 (en)	2008-04-17	needle

Legal Events

Date	Code	Title	Description
2023-01-09	MK1K	Patent expired